Effectiveness of de-escalation for bacteremia: Open-label randomized non-inferior trial.

Effectiveness of de-escalation for bacteremia: Open-label randomized non-inferior trial. - Effectiveness of de-escalation for bacteremia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028380

Enrollment

164

Registered

2017-08-30

Start date

2017-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bacteremia

Interventions

de-escalation no de-escalation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients with bacteremia with positive blood cultures, diagnosed by Infectious Diseases (ID) doctors, treated with broad spectrum antibiotics, and judged to be eligible for de-escalation by ID doctor.

Exclusion criteria

Exclusion criteria: Disagreed to participate in the trial either by the patient or treating physicians.

Design outcomes

Primary

Measure	Time frame
30-day mortality	—

Countries

Japan

Contacts

Public ContactToko Nakata

Kobe University Division of Infectious Diseases

kobeid@med.kobe-u.ac.jp078-382-6297

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026